Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-25 @ 2:27 AM
NCT ID:
NCT02645734
Eligibility Criteria:
Inclusion Criteria:
* The patient at least 18 years old had type 1 or 2 diabetes who presented with Central DME involvement (defined as retinal thickening involving 1mm central sub field thickness(CCT)
* Have at least a BCVA ( best corrected visual acuity) between 20/50 to 20/320 Snellen equivalent
* Have received to anti-VEGF( anti -vascular endothelial growth factor) and laser treatment within the previous 3 months
Exclusion Criteria:
* Uncontrolled glaucoma/uncontrolled diabet , high risk PRP(pan-retinal photocoagulation), one eye
* Prior treatment with intravitreal or peribulbar injection and laser therapy during the last 3 months
* Substantial cataract, history of uveitis
* Macular edema due to a cause other than DME
* VMT(Vitreomacular traction ) and ERM (epiretinal membrane)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02645734
Study Brief:
Protocol Section:
NCT02645734